TCM
IMUC

Tradewinds Capital Management’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Tradewinds Capital Management’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed – – 723
2018
Q3 		$0 Hold
200
– – ﹤0.01% 724
2018
Q2 		$0 Hold
200
– – ﹤0.01% 716
2018
Q1 		$0 Hold
200
– – ﹤0.01% 776
2017
Q4 		$0 Buy
+200
New +$68 ﹤0.01% 781

Other funds holding IMUC

Wedbush Securities
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Tradewinds Capital Management's IMUC Position: Q4 2018 in Review

Tradewinds Capital Management sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 200 shares.

Tradewinds Capital Management first reported a position in IMUC in Q4 2017 and held it in 4 quarters. The position peaked at $0 in Q3 2018. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.

  • Tradewinds Capital Management reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
  • Tradewinds Capital Management sold 200 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018.
  • Tradewinds Capital Management first reported a position in ImmunoCellular Therapeutics, Ltd. in Q4 2017 and held it in 4 quarters.
  • Tradewinds Capital Management's ImmunoCellular Therapeutics, Ltd. position peaked at $0 in Q3 2018.
  • 3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.

Based on Tradewinds Capital Management's 13F filing for Q4 2018, filed 31 Jan 2019.